Targeted delivery of mesenchymal stem cells to the bone

Bone

Volumn 70, Issue , 2015, Pages 62-65

  Yao, Wei ^a   Lane, Nancy E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bone mass; Bone strength; Mesenchymal stem cells; Osteoblasts; Osteoporosis

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; BETA1 INTEGRIN; CD51 ANTIGEN; COLLAGEN TYPE 1; FIBRONECTIN; OSTEONECTIN; SIALOPROTEIN; ALENDRONIC ACID; CARBANILAMIDE DERIVATIVE; DIPEPTIDE; ESTROGEN; LLP2A COMPOUND;

ARTICLE; BONE MASS; BONE MATRIX; BONE MINERALIZATION; BONE STRENGTH; CELL ADHESION; CELL AGING; CELL INTERACTION; CELL MATURATION; CORTICAL BONE; EXTRACELLULAR MATRIX; FRACTURE HEALING; FRAGILITY FRACTURE; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCYTE; OSTEOLYSIS; OSTEOPOROSIS; PROTEIN EXPRESSION; TRABECULAR BONE; AGING; ANIMAL; BONE; C57BL MOUSE; CYTOLOGY; DEFICIENCY; DRUG EFFECTS; IMMUNOCOMPETENCE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; MOUSE; PHYSIOLOGY;

AGING; ALENDRONATE; ANIMALS; BONE AND BONES; DIPEPTIDES; ESTROGENS; IMMUNOCOMPETENCE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; PHENYLUREA COMPOUNDS;

EID: 84918552423     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2014.07.026     Document Type: Article

References (44)

1. Cummings S.R., Cosman F., Eastell R., Reid I.R., Mehta M., Lewiecki E.M. Goal-directed treatment of osteoporosis. J Bone Miner Res 2013, 28:433-438.
2. Diab D.L., Watts N.B. Postmenopausal osteoporosis. Curr Opin Endocrinol Diabetes Obes 2013, 20:501-509.
3. Neer R.M., Arnaud C.D., Zanchetta J.R., Prince R., Gaich G.A., Reginster J.Y., et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001, 344:1434-1441.
4. Stolzing A., Jones E., McGonagle D., Scutt A. Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev 2008, 129:163-173.
5. Katsara O., Mahaira L.G., Iliopoulou E.G., Moustaki A., Antsaklis A., Loutradis D., et al. Effects of donor age, gender, and in vitro cellular aging on the phenotypic, functional, and molecular characteristics of mouse bone marrow-derived mesenchymal stem cells. Stem Cells Dev 2011, 20:1549-1561.
6. Bonyadi M., Waldman S.D., Liu D., Aubin J.E., Grynpas M.D., Stanford W.L. Mesenchymal progenitor self-renewal deficiency leads to age-dependent osteoporosis in Sca-1/Ly-6A null mice. Proc Natl Acad Sci U S A 2003, 100:5840-5845.
7. Cho S.W., Sun H.J., Yang J.Y., Jung J.Y., An J.H., Cho H.Y., et al. Transplantation of mesenchymal stem cells overexpressing RANK-Fc or CXCR4 prevents bone loss in ovariectomized mice. Mol Ther 2009, 17:1979-1987.
8. Granero-Molto F., Weis J.A., Miga M.I., Landis B., Myers T.J., O'Rear L., et al. Regenerative effects of transplanted mesenchymal stem cells in fracture healing. Stem Cells 2009, 27:1887-1898.
9. Meyerrose T.E., De Ugarte D.A., Hofling A.A., Herrbrich P.E., Cordonnier T.D., Shultz L.D., et al. In vivo distribution of human adipose-derived mesenchymal stem cells in novel xenotransplantation models. Stem Cells 2007, 25:220-227.
10. Gutwald R., Haberstroh J., Kuschnierz J., Kister C., Lysek D.A., Maglione M., et al. Mesenchymal stem cells and inorganic bovine bone mineral in sinus augmentation: comparison with augmentation by autologous bone in adult sheep. Br J Oral Maxillofac Surg 2010, 48:285-290.
11. Vertenten G., Lippens E., Girones J., Gorski T., Declercq H., Saunders J., et al. Evaluation of an injectable, photopolymerizable, and three-dimensional scaffold based on methacrylate-endcapped poly(D, L-lactide-co-epsilon-caprolactone) combined with autologous mesenchymal stem cells in a goat tibial unicortical defect model. Tissue Eng A 2009, 15:1501-1511.
12. Longobardi L., Granero-Molto F., O'Rear L., Myers T.J., Li T., Kregor P.J., et al. Subcellular localization of IRS-1 in IGF-I-mediated chondrogenic proliferation, differentiation and hypertrophy of bone marrow mesenchymal stem cells. Growth Factors 2009, 27:309-320.
13. Halleux C., Sottile V., Gasser J.A., Seuwen K. Multi-lineage potential of human mesenchymal stem cells following clonal expansion. J Musculoskelet Nueronal Interact 2001, 2:71-76.
14. Kitaori T., Ito H., Schwarz E.M., Tsutsumi R., Yoshitomi H., Oishi S., et al. Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. Arthritis Rheum 2009, 60:813-823.
15. Chapel A., Bertho J.M., Bensidhoum M., Fouillard L., Young R.G., Frick J., et al. Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome. J Gene Med 2003, 5:1028-1038.
16. Dreger T., Watson J.T., Akers W., Molligan J., Achilefu S., Schon L.C., et al. Intravenous application of CD271-selected mesenchymal stem cells during fracture healing. J Orthop Trauma 2014, 28(Suppl. 1):S15-S19.
17. Peterson B., Zhang J., Iglesias R., Kabo M., Hedrick M., Benhaim P., et al. Healing of critically sized femoral defects, using genetically modified mesenchymal stem cells from human adipose tissue. Tissue Eng 2005, 11:120-129.
18. + cells for patients with femoral and tibial nonunion: pilot clinical trial. Stem Cells Transl Med 2014, 3:128-134.
19. Liu X., Liao X., Luo E., Chen W., Bao C., Xu H.H. Mesenchymal stem cells systemically injected into femoral marrow of dogs home to mandibular defects to enhance new bone formation. Tissue Eng A 2014, 20:883-892.
20. Bahney C.S., Hu D.P., Taylor A.J., Ferro F., Britz H.M., Hallgrimsson B., et al. Stem cell-derived endochondral cartilage stimulates bone healing by tissue transformation. J Bone Miner Res 2014, 29:1269-1282.
21. Jürg A., Gasser L.C.C., Kamibayashi Lynne K. Intravenously administered mesenchymal OVX-induced bone loss in distribution of labelled MSCs. J Bone Miner Res 1999, 14:1.
22. Fu J., Wang Y.K., Yang M.T., Desai R.A., Yu X., Liu Z., et al. Mechanical regulation of cell function with geometrically modulated elastomeric substrates. Nat Methods 2010, 7:733-736.
23. Adams G.B., Chabner K.T., Alley I.R., Olson D.P., Szczepiorkowski Z.M., Poznansky M.C., et al. Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor. Nature 2006, 439:599-603.
24. Chen X.D., Dusevich V., Feng J.Q., Manolagas S.C., Jilka R.L. Extracellular matrix made by bone marrow cells facilitates expansion of marrow-derived mesenchymal progenitor cells and prevents their differentiation into osteoblasts. J Bone Miner Res 2007, 22:1943-1956.
25. Mukherjee S., Raje N., Schoonmaker J.A., Liu J.C., Hideshima T., Wein M.N., et al. Pharmacologic targeting of a stem/progenitor population in vivo is associated with enhanced bone regeneration in mice. J Clin Invest 2008, 118:491-504.
26. Grzesik W.J., Robey P.G. Bone matrix RGD glycoproteins: immunolocalization and interaction with human primary osteoblastic bone cells in vitro. J Bone Miner Res 1994, 9:487-496.
27. Vukicevic S., Luyten F.P., Kleinman H.K., Reddi A.H. Differentiation of canalicular cell processes in bone cells by basement membrane matrix components: regulation by discrete domains of laminin. Cell 1990, 63:437-445.
28. Mbalaviele G., Shin C.S., Civitelli R. Cell-cell adhesion and signaling through cadherins: connecting bone cells in their microenvironment. J Bone Miner Res 2006, 21:1821-1827.
29. Gronthos S., Akintoye S.O., Wang C.Y., Shi S. Bone marrow stromal stem cells for tissue engineering. Periodontol 2000 2006, 41:188-195.
30. Gronthos S., Simmons P.J., Graves S.E., Robey P.G. Integrin-mediated interactions between human bone marrow stromal precursor cells and the extracellular matrix. Bone 2001, 28:174-181.
31. Gronthos S., Stewart K., Graves S.E., Hay S., Simmons P.J. Integrin expression and function on human osteoblast-like cells. J Bone Miner Res 1997, 12:1189-1197.
32. Brooke G., Tong H., Levesque J.P., Atkinson K. Molecular trafficking mechanisms of multipotent mesenchymal stem cells derived from human bone marrow and placenta. Stem Cells Dev 2008, 17:929-940.
33. Cowles E.A., Brailey L.L., Gronowicz G.A. Integrin-mediated signaling regulates AP-1 transcription factors and proliferation in osteoblasts. J Biomed Mater Res 2000, 52:725-737.
34. Hamidouche Z., Fromigue O., Ringe J., Haupl T., Vaudin P., Pages J.C., et al. Priming integrin alpha5 promotes human mesenchymal stromal cell osteoblast differentiation and osteogenesis. Proc Natl Acad Sci U S A 2009, 106:18587-18591.
35. Murphy M.B., Moncivais K., Caplan A.I. Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine. Exp Mol Med 2013, 45:e54.
36. Lee J.W., Fang X., Krasnodembskaya A., Howard J.P., Matthay M.A. Concise review: mesenchymal stem cells for acute lung injury: role of paracrine soluble factors. Stem Cells 2011, 29:913-919.
37. Kolbe M., Xiang Z., Dohle E., Tonak M., Kirkpatrick C.J., Fuchs S. Paracrine effects influenced by cell culture medium and consequences on microvessel-like structures in cocultures of mesenchymal stem cells and outgrowth endothelial cells. Tissue Eng A 2011, 17:2199-2212.
38. Guan M., Yao W., Liu R., Lam K.S., Nolta J., Jia J., et al. Directing mesenchymal stem cells to bone to augment bone formation and increase bone mass. Nat Med 2012, 18:456-462.
39. Yao W., Guan M., Jia J., Dai W., Lay Y.A., Amugongo S., et al. Reversing bone loss by directing mesenchymal stem cells to bone. Stem Cells 2013, 31:2003-2014.
40. Hess D.A., Craft T.P., Wirthlin L., Hohm S., Zhou P., Eades W.C., et al. Widespread nonhematopoietic tissue distribution by transplanted human progenitor cells with high aldehyde dehydrogenase activity. Stem Cells 2008, 26:611-620.
41. Meyerrose T., De Ugarte D., Hofling A., Herrbrich P.E., Cordonnier T.D., Shultz L.D., et al. In vivo distribution of human adipose-derived mesenchymal stem cells in novel xenotransplantation models. Stem Cells 2007, 25:220-227.
42. Meyerrose T.E., Roberts M., Ohlemiller K.K., Vogler C.A., Wirthlin L., Nolta J.A., et al. Lentiviral-transduced human mesenchymal stem cells persistently express therapeutic levels of enzyme in a xenotransplantation model of human disease. Stem Cells 2008, 26:1713-1722.
43. Sethe S., Scutt A., Stolzing A. Aging of mesenchymal stem cells. Ageing Res Rev 2006, 5:91-116.
44. Brack A.S., Rando T.A. Intrinsic changes and extrinsic influences of myogenic stem cell function during aging. Stem Cell Rev 2007, 3:226-237.